Disease activity score
Disease activity score, also called DAS28, is a measure widely used in measuring the response to treatment in rheumatoid arthritis.
Joints included in DAS28[edit]
Bilateral proximal interphalangeal joints total of 10 joints Bilateral metacarpophalangeal joints total of 10 Bilateral wrists total of 2, Bilateral elbows total of 2, Bilateral shoulders total of 2 and Bilateral knees total of 2.
What is measured in DAS28?[edit]
In any of the joints, tenderness upon touching which gives the TEN28 score and joint swelling of the joints which gives SW28 are counted.
Sed rate measurement[edit]
The erythrocyte sedimentation rate (ESR) is also measured.
Subjective assessment[edit]
The affected person makes a subjective assessment (SA) of disease activity during the preceding 7 days on a scale between 0 and 100, where 0 is "no activity" and 100 is "highest activity possible".
How is DAS28 calculated?[edit]
With the above parameters, DAS28 is calculated as:
From this, the disease activity of the affected person can be classified as follows:
| Current
DAS28 |
DAS28 decrease from initial value | |||
|---|---|---|---|---|
| > 1.2 | > 0.6 but ≤ 1.2 | ≤ 0.6 | ||
| ≤ 3.2 | Inactive | Good improvement | Moderate improvement | No improvement |
| > 3.2 but ≤ 5.1 | Moderate | Moderate improvement | Moderate improvement | No improvement |
| > 5.1 | Very active | Moderate improvement | No improvement | No improvement |
Clinical utility of DAS28 score[edit]
Although it gives a good indication of the disease activity, it is not always a reliable indicator of treatment effect.
Limitations of DAS28 score[edit]
One major limitation is that low-grade synovitis may be missed.
Also see[edit]
- ACR-EULAR Provisional Definition of Remission of Rheumatoid arthritis,
- Simplified Disease Activity Index and
- Clinical Disease Activity Index.
- Some scores do not require input from a healthcare professional and allow self-monitoring by the person, like Health Assessment Questionnaire Disability Index (HAQ-DI).
| Diseases of joints | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Hypersensitivity and autoimmune diseases (279.5–6) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
